Radiopharmaceutical Indications Should Not Be Disease Specific - CORAR
This article was originally published in The Gray Sheet
Disease specific radiopharmaceutical indications should not be required by FDA, Council on Radionuclides and Radiopharmaceuticals Secretary Robert Morgan (DuPont Merck) maintained at a Feb. 27 public meeting.
You may also be interested in...
As distribution of Regeneron’s monoclonal antibody treatment for coronavirus begins, OWS officials worry about provider confusion with Lilly’s product due to differences in preparation and administration.
The maker of prestige-inspired cosmetics at value prices follows its TikTok viral success by teaming with Kathleen Belsten, aka Loserfruit, the second most-followed female gamer on the Amazon-owned livestreaming platform Twitch.
Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things.